Patent ID: 9018246
Filing Date: 2015-04-28
Classification: A61K,A61P

Abstract:
1. A method for treating cancer in a subject, comprising: identifying a subject suffering from cancer, and administering to the buccal mucosa or sublingual mucosa of the subject a pharmaceutical formulation comprising an effective amount of a taxane selected from the group consisting of docetaxel, paclitaxel, cabazitaxel, and larotaxel, the pharmaceutical formulation comprises 0.15-10% (w/v) of the taxane, 20-60% (w/v) of a non-ionic surfactant, a viscosity enhancing agent to provide a viscosity of 200-400 CP, 2-30% (w/v) of an adhesive agent, and 10-75% (w/v) of ethanol, the pH of the pharmaceutical formulation is 4-6, and the cancer is ovarian cancer, breast cancer, lung cancer, prostate cancer, or gastric cancer.